Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile Processing), Process Technology (Ultrafiltration; Microfiltration), Design/Process, End-Users & Region - Global Forecast to 2030

1 INTRODUCTION 32 1.1 STUDY OBJECTIVES 32 1.2 MARKET DEFINITION 32 1.3 STUDY SCOPE 33 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 33 1.3.2 INCLUSIONS & EXCLUSIONS 34 1.3.3 YEARS CONSIDERED 34 1.3.4 CURRENCY CONSIDERED 34 1.3.5 UNITS CONSIDERED 34 1.4 STAKEHOLDERS 35 1.5 SUMMARY OF CHANGES 35 2 RESEARCH METHODOLOGY 36 2.1 RESEARCH DATA 36 2.1.1 SECONDARY DATA 37 2.1.1.1 List of key secondary sources 37 2.1.1.2 Key data from secondary sources 37 2.1.2 PRIMARY DATA 38 2.1.2.1 Key data from primary sources 38 2.1.2.2 List of key primary interview participants 39 2.1.2.3 Key industry insights 39 2.1.2.4 Breakdown of interviews with experts 39 2.2 MARKET SIZE ESTIMATION 40 2.2.1 BOTTOM-UP APPROACH 40 2.2.2 TOP-DOWN APPROACH 41 2.3 GROWTH FORECAST 42 2.4 DATA TRIANGULATION 43 2.5 FACTOR ANALYSIS 44 2.6 RESEARCH ASSUMPTIONS 44 2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS 45 3 EXECUTIVE SUMMARY 46 4 PREMIUM INSIGHTS 50 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL FILTRATION MARKET 50 4.2 MEDICAL FILTRATION MARKET, BY MATERIAL 50 4.3 MEDICAL FILTRATION MARKET, BY APPLICATION 51 4.4 MEDICAL FILTRATION MARKET, BY END USER 51 4.5 MEDICAL FILTRATION MARKET, BY KEY COUNTRY 52 5 MARKET OVERVIEW 53 5.1 INTRODUCTION 53 5.2 MARKET DYNAMICS 53 5.2.1 DRIVERS 54 5.2.1.1 Increasing demand for advanced healthcare solutions 54 5.2.1.2 Rising awareness of infection control 56 5.2.1.3 Technological advancements 56 5.2.2 RESTRAINTS 56 5.2.2.1 High capital investments 56 5.2.2.2 Stringent regulatory compliance 57 5.2.3 OPPORTUNITIES 57 5.2.3.1 Growing healthcare investments in emerging economies 57 5.2.3.2 Adoption of single-use technologies 57 5.2.4 CHALLENGES 58 5.2.4.1 Speed and yield issues 58 5.3 PORTER’S FIVE FORCES ANALYSIS 59 5.3.1 THREAT OF NEW ENTRANTS 59 5.3.2 THREAT OF SUBSTITUTES 60 5.3.3 BARGAINING POWER OF SUPPLIERS 60 5.3.4 BARGAINING POWER OF BUYERS 60 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 60 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 61 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 61 5.4.2 QUALITY 62 5.4.3 SERVICE 62 5.5 MACROECONOMIC OUTLOOK 63 5.5.1 GDP TRENDS AND FORECASTS 63 5.6 IMPACT OF AI/GEN AI 66 5.7 VALUE CHAIN ANALYSIS 67 5.7.1 RAW MATERIAL SUPPLIERS 67 5.7.2 MANUFACTURERS 67 5.7.3 DISTRIBUTORS 67 5.7.4 END USERS 68 5.8 ECOSYSTEM ANALYSIS 68 5.9 CASE STUDY ANALYSIS 69 5.9.1 VALIDATING PEGASUS PRIME VIRUS REMOVAL FILTERS WITH PREFILTERS 69 5.9.2 ENHANCING DIALYSIS FILTRATION EFFICIENCY – FRESENIUS MEDICAL CARE 70 5.9.3 BLOOD FILTRATION FOR SEPSIS TREATMENT – CYTOSORBENTS CORPORATION 71 5.10 TARIFF AND REGULATORY LANDSCAPE 71 5.10.1 ENVIRONMENTAL REGULATIONS 71 5.10.2 NORTH AMERICA 71 5.10.3 ASIA PACIFIC 72 5.10.4 EUROPE 72 5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 5.11 TECHNOLOGY ANALYSIS 75 5.11.1 KEY TECHNOLOGIES 75 5.11.1.1 Microfiltration 75 5.11.1.2 Ultrafiltration 75 5.11.1.3 Nanofiltration 75 5.11.2 COMPLEMENTARY TECHNOLOGIES 76 5.11.2.1 Single-use technology 76 5.11.3 ADJACENT TECHNOLOGIES 76 5.11.3.1 Chromatography 76 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77 5.13 TRADE ANALYSIS 78 5.13.1 EXPORT SCENARIO (HS CODE 8421) 78 5.13.2 IMPORT SCENARIO (HS CODE 8421) 79 5.14 KEY CONFERENCES AND EVENTS, 2025–2026 80 5.15 PRICING ANALYSIS 82 5.15.1 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 82 5.15.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023 83 5.15.3 AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023 83 5.16 INVESTMENT AND FUNDING SCENARIO 84 5.17 PATENT ANALYSIS 84 5.17.1 INTRODUCTION 84 5.17.2 LEGAL STATUS OF PATENTS 86 5.17.3 JURISDICTION ANALYSIS 86 6 MEDICAL FILTRATION MARKET, BY MATERIAL 87 6.1 INTRODUCTION 88 6.2 POLYSULFONE & POLYETHERSULFONE 90 6.2.1 EXCELLENT MECHANICAL STRENGTH, THERMAL STABILITY, AND CHEMICAL RESISTANCE TO BOOST MARKET 90 6.3 POLYVINYLIDENE FLUORIDE 90 6.3.1 EXCEPTIONAL CHEMICAL RESISTANCE, THERMAL STABILITY, AND MECHANICAL STRENGTH TO DRIVE MARKET 90 6.4 POLYTETRAFLUOROETHYLENE 91 6.4.1 SUPERIOR FILTRATION PERFORMANCE IN CRITICAL MEDICAL APPLICATIONS TO PROPEL DEMAND 91 6.5 POLYPROPYLENE 91 6.5.1 EXCELLENT CHEMICAL RESISTANCE, DURABILITY, AND COST-EFFECTIVENESS TO DRIVE DEMAND 91 6.6 OTHER MATERIALS 92 7 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY 93 7.1 INTRODUCTION 94 7.2 ULTRAFILTRATION 96 7.2.1 INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASE AND RISING DEMAND FOR DIALYSIS TREATMENTS TO BOOST MARKET 96 7.3 MICROFILTRATION 96 7.3.1 GROWING USAGE IN STERILIZATION, WATER PURIFICATION, AND BIOPHARMACEUTICAL MANUFACTURING TO DRIVE DEMAND 96 7.4 NANOFILTRATION 97 7.4.1 LOW ENERGY CONSUMPTION AND HIGH FILTRATION EFFICIENCY TO SUPPORT MARKET GROWTH 97 7.5 REVERSE OSMOSIS 97 7.5.1 CRUCIAL ROLE IN ENSURING SAFETY OF WATER IN MEDICAL PROCEDURES TO BOOST MARKET 97 7.6 GAS FILTRATION 98 7.6.1 DELIVERY OF HIGH-QUALITY FILTERED AIR TO FUEL GROWTH 98 7.7 OTHER PROCESS TECHNOLOGIES 98 8 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS 99 8.1 INTRODUCTION 100 8.2 SYSTEMS (RTU UNITS) 101 8.2.1 CONVENIENCE, TIME-SAVING BENEFITS, AND ABILITY TO ENSURE CONSISTENT FILTRATION PERFORMANCE TO BOOST MARKET 101 8.3 FILTRATION MODULES (CONSUMABLES) 102 8.3.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND FOR FILTRATION MODULES IN HEALTHCARE 102 8.4 OTHER DESIGNS/PROCESSES 102 9 MEDICAL FILTRATION MARKET, BY END USER 103 9.1 INTRODUCTION 104 9.2 HOSPITALS 106 9.2.1 REQUIREMENT OF HIGH-PURITY WATER FOR WOUND CARE, SURGICAL PROCEDURES, STERILIZATION, AND DIALYSIS TO DRIVE MARKET 106 9.3 DIAGNOSTIC CENTERS 106 9.3.1 DEMAND FOR HIGH-PURITY WATER, FLUIDS, AND AIR TO ENSURE RELIABLE DIAGNOSTICS TO DRIVE GROWTH 106 9.4 RESEARCH INSTITUTES 107 9.4.1 INCREASE IN BIOLOGICAL STUDIES, AND MEDICAL RESEARCH TO BOOST MARKET 107 9.5 OTHER END USERS 107   10 MEDICAL FILTRATION MARKET, BY APPLICATION 108 10.1 INTRODUCTION 109 10.2 DIALYSIS 111 10.2.1 ACCURACY AND OPERATIONAL FILTRATION EFFICIENCY IN BLOOD PURIFICATION TO BOOST GROWTH 111 10.3 DRUG DELIVERY 111 10.3.1 PROVISION OF OPTIMAL CONDITIONS THROUGH CONSISTENT FLOW RATES AND MINIMUM PRESSURE DROPS TO FUEL MARKET GROWTH 111 10.4 IV INFUSION & STERILE FILTRATION 112 10.4.1 HIGH LEVEL OF PRECISION IN CONTAMINANT REMOVAL WHILE PRESERVING FLUID INTEGRITY TO DRIVE GROWTH 112 10.5 ENDOSCOPY 112 10.5.1 ENHANCEMENT OF SAFETY AND PERFORMANCE WITH ADVANCED FILTRATION TO BOOST MARKET 112 10.6 STERILE PROCESSING 113 10.6.1 GROWING DEMAND FOR SURGICAL INSTRUMENTS, ENDOSCOPES, AND REUSABLE MEDICAL DEVICES TO PROPEL MARKET 113 10.7 BIO-ARTIFICIAL PROCESSES 113 10.7.1 VITAL ROLE OF SOPHISTICATED FILTRATION SYSTEMS IN DEVELOPMENT AND FUNCTIONALITY OF BIO-ARTIFICIAL ORGANS TO BOOST MARKET 113 10.8 OTHER APPLICATIONS 114 11 MEDICAL FILTRATION MARKET, BY REGION 115 11.1 INTRODUCTION 116 11.2 ASIA PACIFIC 118 11.2.1 CHINA 127 11.2.1.1 Strong economic growth and expanding healthcare sector to drive market 127 11.2.2 JAPAN 129 11.2.2.1 Growing aging population to propel market 129 11.2.3 INDIA 131 11.2.3.1 Increasing investments in healthcare sector to drive market 131 11.2.4 SOUTH KOREA 133 11.2.4.1 Rising demand for high-quality medical filtration solutions to drive market 133 11.2.5 REST OF ASIA PACIFIC 135 11.3 EUROPE 137 11.3.1 GERMANY 146 11.3.1.1 Economic strength, increasing healthcare expenditure, and rapidly aging population to drive market 146 11.3.2 UK 148 11.3.2.1 Rising geriatric population to support market growth 148 11.3.3 FRANCE 150 11.3.3.1 Aging population and enhancement of healthcare system to propel market 150 11.3.4 ITALY 151 11.3.4.1 Growing aging population to increase demand 151 11.3.5 SPAIN 153 11.3.5.1 Rising demand for advanced medical solutions to propel market 153 11.3.6 REST OF EUROPE 155 11.4 NORTH AMERICA 157 11.4.1 US 165 11.4.1.1 Stringent regulatory guidelines and increasing healthcare spending to boost market 165 11.4.2 CANADA 167 11.4.2.1 Growing aging population and significant government investments in healthcare infrastructure to drive market growth 167 11.4.3 MEXICO 169 11.4.3.1 Government initiatives and growth of healthcare sector to drive market 169 11.5 MIDDLE EAST & AFRICA 171 11.5.1 GCC COUNTRIES 179 11.5.1.1 Saudi Arabia 179 11.5.1.1.1 Economic growth, increasing government investments, and rising healthcare expenditures to drive market 179 11.5.1.2 Rest of GCC Countries 181 11.5.2 SOUTH AFRICA 183 11.5.2.1 Outbreaks of contagious diseases to drive demand 183 11.5.3 REST OF MIDDLE EAST & AFRICA 184 11.6 SOUTH AMERICA 186 11.6.1 BRAZIL 194 11.6.1.1 Rising healthcare investments and expanding medical infrastructure to propel growth 194 11.6.2 ARGENTINA 195 11.6.2.1 Increasing healthcare expenditure and enhancement of medical infrastructure to drive market 195 11.6.3 REST OF SOUTH AMERICA 197 12 COMPETITIVE LANDSCAPE 200 12.1 OVERVIEW 200 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 200 12.3 REVENUE ANALYSIS, 2021–2023 202 12.4 MARKET SHARE ANALYSIS, 2023 203 12.5 COMPANY VALUATION AND FINANCIAL METRICS 205 12.6 PRODUCT COMPARISON 206 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 207 12.7.1 STARS 207 12.7.2 EMERGING LEADERS 208 12.7.3 PERVASIVE PLAYERS 208 12.7.4 PARTICIPANTS 208 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 209 12.7.5.1 Region footprint 210 12.7.5.2 Material footprint 211 12.7.5.3 Process technology footprint 212 12.7.5.4 Design/Process footprint 213 12.7.5.5 Application footprint 214 12.7.5.6 End user footprint 215 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 216 12.8.1 PROGRESSIVE COMPANIES 216 12.8.2 RESPONSIVE COMPANIES 216 12.8.3 DYNAMIC COMPANIES 216 12.8.4 STARTING BLOCKS 216 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 218 12.8.5.1 Detailed list of key startups/SMEs 218 12.8.5.2 Competitive benchmarking of key startups/SMEs 219 12.9 COMPETITIVE SCENARIO 220 12.9.1 PRODUCT LAUNCHES 220 12.9.2 DEALS 221 12.9.3 EXPANSIONS 222 12.9.4 OTHER DEVELOPMENTS 223 13 COMPANY PROFILES – MEDICAL FILTRATION EQUIPMENT PROVIDERS 224 13.1 KEY PLAYERS 224 13.1.1 MERCK KGAA 224 13.1.1.1 Business overview 224 13.1.1.2 Products/Solutions/Services offered 225 13.1.1.3 Recent developments 228 13.1.1.3.1 Expansions 228 13.1.1.4 MnM view 229 13.1.1.4.1 Right to win 229 13.1.1.4.2 Strategic choices 229 13.1.1.4.3 Weaknesses and competitive threats 230 13.1.2 3M (SOLVENTUM) 231 13.1.2.1 Business overview 231 13.1.2.2 Products/Solutions/Services offered 232 13.1.2.3 Recent developments 234 13.1.2.3.1 Other developments 234 13.1.2.4 MnM view 235 13.1.2.4.1 Right to win 235 13.1.2.4.2 Strategic choices 235 13.1.2.4.3 Weaknesses and competitive threats 235 13.1.3 DANAHER 236 13.1.3.1 Business overview 236 13.1.3.2 Products/Solutions/Services offered 237 13.1.3.3 Recent developments 240 13.1.3.3.1 Deals 240 13.1.3.3.2 Other developments 241 13.1.3.4 MnM view 241 13.1.3.4.1 Right to win 241 13.1.3.4.2 Strategic choices 241 13.1.3.4.3 Weaknesses and competitive threats 242 13.1.4 SARTORIUS AG 243 13.1.4.1 Business overview 243 13.1.4.2 Products/Solutions/Services offered 244 13.1.4.3 Recent developments 247 13.1.4.3.1 Product launches 247 13.1.4.4 MnM view 247 13.1.4.4.1 Right to win 247 13.1.4.4.2 Strategic choices 247 13.1.4.4.3 Weaknesses and competitive threats 247 13.1.5 ASAHI KASEI CORPORATION 248 13.1.5.1 Business overview 248 13.1.5.2 Products/Solutions/Services offered 249 13.1.5.3 MnM view 250 13.1.5.3.1 Right to win 250 13.1.5.3.2 Strategic choices 250 13.1.5.3.3 Weaknesses and competitive threats 250 13.1.6 BAXTER 251 13.1.6.1 Business overview 251 13.1.6.2 Products/Solutions/Services offered 252 13.1.6.3 Recent developments 254 13.1.6.3.1 Deals 254 13.1.6.4 MnM view 255 13.1.6.4.1 Right to win 255 13.1.6.4.2 Strategic choices 255 13.1.6.4.3 Weaknesses and competitive threats 255 13.1.7 THERMO FISHER SCIENTIFIC INC. 256 13.1.7.1 Business overview 256 13.1.7.2 Products/Solutions/Services offered 257 13.1.7.3 MnM view 260   13.1.8 VEOLIA 261 13.1.8.1 Business overview 261 13.1.8.2 Products/Solutions/Services offered 262 13.1.8.3 Recent developments 266 13.1.8.3.1 Product launches 266 13.1.8.4 MnM view 267 13.1.8.4.1 Right to win 267 13.1.8.4.2 Strategic choices 267 13.1.8.4.3 Weaknesses and competitive threats 267 13.1.9 DONALDSON COMPANY, INC. 268 13.1.9.1 Business overview 268 13.1.9.2 Products/Solutions/Services offered 269 13.1.9.3 Recent developments 270 13.1.9.3.1 Expansions 270 13.1.9.4 MnM view 270 13.1.10 PARKER HANNIFIN CORP 271 13.1.10.1 Business overview 271 13.1.10.2 Products/Solutions/Services offered 272 13.1.10.3 MnM view 273 13.1.11 ENTEGRIS 274 13.1.11.1 Business overview 274 13.1.11.2 Products/Solutions/Services offered 275 13.1.11.3 MnM view 275 13.1.12 MANN+HUMMEL 276 13.1.12.1 Business overview 276 13.1.12.2 Products/Solutions/Services offered 277 13.1.12.3 MnM view 278 13.2 OTHER PLAYERS 279 13.2.1 CORNING INCORPORATED 279 13.2.2 CRITICAL PROCESS FILTRATION, INC. 280 13.2.3 COBETTER 281 13.2.4 GRAVER TECHNOLOGIES 282 13.2.5 ERTELALSOP 284 13.2.6 KASAG SWISS AG 285 13.2.7 FILTROX AG 286 13.2.8 MEMBRANE SOLUTIONS 287 13.2.9 COLE-PARMER INSTRUMENT COMPANY, LLC 288 13.2.10 MEISSNER FILTRATION PRODUCTS, INC. 289 13.2.11 MEDICAL FILTRATION SOLUTIONS LTD. 290 13.2.12 SEFAR AG 291 13.2.13 WALKER FILTRATION 292 13.2.14 SAINT-GOBAIN 293 14 COMPANY PROFILES - AUTOMATED ENDOSCOPE REPROCESSOR PROVIDERS 294 14.1 KEY PLAYERS 294 14.1.1 STERIS 294 14.1.1.1 Business overview 294 14.1.1.2 Products/Solutions/Services offered 295 14.1.1.3 Recent developments 297 14.1.1.3.1 Deals 297 14.1.1.4 MnM view 297 14.1.1.4.1 Right to win 297 14.1.1.4.2 Strategic choices 298 14.1.1.4.3 Weaknesses and competitive threats 298 14.1.2 FORTIVE 299 14.1.2.1 Business overview 299 14.1.2.2 Products/Solutions/Services offered 300 14.1.2.3 Recent developments 301 14.1.2.3.1 Deals 301 14.1.2.4 MnM view 301 14.1.2.4.1 Right to win 301 14.1.2.4.2 Strategic choices 302 14.1.2.4.3 Weaknesses and competitive threats 302 14.1.3 OLYMPUS CORPORATION 303 14.1.3.1 Business overview 303 14.1.3.2 Products/Solutions/Services offered 304 14.1.3.3 Recent developments 305 14.1.3.3.1 Product launches 305 14.1.3.4 MnM view 305 14.1.3.4.1 Right to win 305 14.1.3.4.2 Strategic choices 305 14.1.3.4.3 Weaknesses and competitive threats 305 14.1.4 ECOLAB 306 14.1.4.1 Business overview 306 14.1.4.2 Products/Solutions/Services offered 307 14.1.4.3 Recent developments 308 14.1.4.3.1 Product launches 308 14.1.4.4 MnM view 308 14.1.4.4.1 Right to win 308 14.1.4.4.2 Strategic choices 308 14.1.4.4.3 Weaknesses and competitive threats 309   14.1.5 GETINGE 310 14.1.5.1 Business overview 310 14.1.5.2 Products/Solutions/Services offered 311 14.1.5.3 Recent developments 312 14.1.5.3.1 Expansions 312 14.1.5.4 MnM view 312 14.1.5.4.1 Right to win 312 14.1.5.4.2 Strategic choices 312 14.1.5.4.3 Weaknesses and competitive threats 313 14.1.6 STEELCOBELIMED (METALL ZUG GROUP) 314 14.1.6.1 Business overview 314 14.1.6.2 Products/Solutions/Services offered 315 14.1.6.3 Recent developments 316 14.1.6.3.1 Deals 316 14.1.6.4 MnM view 316 14.1.7 ENDO-TECHNIK W. GRIESAT (CREO) 317 14.1.7.1 Business overview 317 14.1.7.2 Products/Solutions/Services offered 317 14.1.7.3 MnM view 318 14.1.8 WASSENBURG MEDICAL B.V. (HOYA CORPORATION) 319 14.1.8.1 Business overview 319 14.1.8.2 Products/Solutions/Services offered 319 14.1.8.3 Recent developments 320 14.1.8.3.1 Deals 320 15 COMPANY PROFILES – DIALYSIS EQUIPMENT PROVIDERS 321 15.1 KEY PLAYERS 321 15.1.1 FRESENIUS MEDICAL CARE AG 321 15.1.1.1 Business overview 321 15.1.1.2 Products/Solutions/Services offered 322 15.1.1.3 Recent developments 323 15.1.1.3.1 Product launches 323 15.1.1.3.2 Deals 324 15.1.1.4 MnM view 324 15.1.1.4.1 Right to win 324 15.1.1.4.2 Strategic choices 325 15.1.1.4.3 Weaknesses and competitive threats 325 15.1.2 BAXTER 326 15.1.2.1 Business overview 326 15.1.2.2 Products/Solutions/Services offered 327 15.1.2.3 Recent developments 328 15.1.2.3.1 Deals 328 15.1.2.4 MnM view 329 15.1.2.4.1 Right to win 329 15.1.2.4.2 Strategic choices 329 15.1.2.4.3 Weaknesses and competitive threats 329 15.1.3 DAVITA INC. 330 15.1.3.1 Business overview 330 15.1.3.2 Products/Solutions/Services offered 331 15.1.3.3 Recent developments 331 15.1.3.3.1 Deals 331 15.1.3.3.2 Expansions 332 15.1.3.4 MnM view 332 15.1.3.4.1 Right to win 332 15.1.3.4.2 Strategic choices 332 15.1.3.4.3 Weaknesses and competitive threats 332 15.1.4 NIKKISO CO., LTD. 333 15.1.4.1 Business overview 333 15.1.4.2 Products/Solutions/Services offered 334 15.1.4.3 Recent developments 335 15.1.4.3.1 Deals 335 15.1.4.4 MnM view 336 15.1.4.4.1 Right to win 336 15.1.4.4.2 Strategic choices 336 15.1.4.4.3 Weaknesses and competitive threats 336 15.1.5 B. BRAUN SE 337 15.1.5.1 Business overview 337 15.1.5.2 Products/Solutions/Services offered 338 15.1.5.3 Recent developments 339 15.1.5.3.1 Product launches 339 15.1.5.3.2 Expansions 339 15.1.5.4 MnM view 340 15.1.5.4.1 Right to win 340 15.1.5.4.2 Strategic choices 340 15.1.5.4.3 Weaknesses and competitive threats 340 15.1.6 NIPRO 341 15.1.6.1 Business overview 341 15.1.6.2 Products/Solutions/Services offered 342 15.1.6.3 Recent developments 343 15.1.6.3.1 Product launches 343 15.1.7 TORAY MEDICAL CO., LTD. 344 15.1.7.1 Business overview 344 15.1.7.2 Products/Solutions/Services offered 345   15.1.8 MEDIONICS 346 15.1.8.1 Business overview 346 15.1.8.2 Products/Solutions/Services offered 346 16 APPENDIX 347 16.1 DISCUSSION GUIDE 347 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 350 16.3 CUSTOMIZATION OPTIONS 352 16.4 RELATED REPORTS 352 16.5 AUTHOR DETAILS 353

TABLE 1 CAPITAL HEALTHCARE EXPENDITURE, 2020–2023 (USD MILLION) 54 TABLE 2 HEALTHCARE SPENDING, 2023 (USD MILLION) 55 TABLE 3 MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 61 TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 61 TABLE 5 KEY BUYING CRITERIA FOR TOP THREE END USERS 62 TABLE 6 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019–2023 63 TABLE 7 ANNUAL GDP PERCENTAGE CHANGE AND PROJECTIONS FOR KEY COUNTRIES, 2024–2029 64 TABLE 8 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019–2022 65 TABLE 9 MEDICAL FILTRATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM 69 TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 13 EXPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 78 TABLE 14 IMPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 79 TABLE 15 MEDICAL FILTRATION MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 80 TABLE 16 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 88 TABLE 17 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 89 TABLE 18 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 89 TABLE 19 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION) 89 TABLE 20 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 94 TABLE 21 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 95 TABLE 22 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 95 TABLE 23 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 95 TABLE 24 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 100 TABLE 25 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 101 TABLE 26 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 101 TABLE 27 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 101 TABLE 28 MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 104 TABLE 29 MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 105 TABLE 30 MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION) 105 TABLE 31 MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION) 105 TABLE 32 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 109 TABLE 33 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 110 TABLE 34 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 110 TABLE 35 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 111 TABLE 36 MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (UNIT) 117 TABLE 37 MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (UNIT) 117 TABLE 38 MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (USD MILLION) 117 TABLE 39 MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (USD MILLION) 118 TABLE 40 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 119 TABLE 41 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 120 TABLE 42 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 120 TABLE 43 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 120 TABLE 44 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 121 TABLE 45 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 121 TABLE 46 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 121 TABLE 47 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION) 122 TABLE 48 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 122 TABLE 49 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 122 TABLE 50 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 123 TABLE 51 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 123 TABLE 52 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 123 TABLE 53 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 124 TABLE 54 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 124 TABLE 55 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 124 TABLE 56 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 124 TABLE 57 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 125 TABLE 58 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION) 125 TABLE 59 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION) 125 TABLE 60 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 126 TABLE 61 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 126 TABLE 62 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 126 TABLE 63 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 127 TABLE 64 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 128 TABLE 65 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 128 TABLE 66 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 128 TABLE 67 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 129 TABLE 68 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 129 TABLE 69 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 130 TABLE 70 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 130 TABLE 71 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 130 TABLE 72 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 131 TABLE 73 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 132 TABLE 74 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 132 TABLE 75 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 132 TABLE 76 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 133 TABLE 77 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 134 TABLE 78 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 134 TABLE 79 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 134 TABLE 80 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 135 TABLE 81 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 136 TABLE 82 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 136 TABLE 83 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 137 TABLE 84 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 138 TABLE 85 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 139 TABLE 86 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 139 TABLE 87 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 139 TABLE 88 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 140 TABLE 89 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 140 TABLE 90 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 140 TABLE 91 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION) 141 TABLE 92 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 141 TABLE 93 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 141 TABLE 94 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 142 TABLE 95 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 142 TABLE 96 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 142 TABLE 97 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 143 TABLE 98 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 143 TABLE 99 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 143 TABLE 100 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 143 TABLE 101 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 144 TABLE 102 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION) 144 TABLE 103 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION) 144 TABLE 104 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 145 TABLE 105 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 145 TABLE 106 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 145 TABLE 107 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 146 TABLE 108 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 147 TABLE 109 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 147 TABLE 110 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 147 TABLE 111 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 148 TABLE 112 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 148 TABLE 113 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 149 TABLE 114 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 149 TABLE 115 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 149 TABLE 116 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 150 TABLE 117 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 150 TABLE 118 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 151 TABLE 119 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 151 TABLE 120 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 152 TABLE 121 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 152 TABLE 122 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 152 TABLE 123 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 153 TABLE 124 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 153 TABLE 125 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 154 TABLE 126 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 154 TABLE 127 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 154 TABLE 128 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 155 TABLE 129 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 155 TABLE 130 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 156 TABLE 131 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 156 TABLE 132 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 158 TABLE 133 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 158 TABLE 134 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 158 TABLE 135 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 158 TABLE 136 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 159 TABLE 137 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 159 TABLE 138 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 159 TABLE 139 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION) 160 TABLE 140 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 160 TABLE 141 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 160 TABLE 142 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 161 TABLE 143 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 161 TABLE 144 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 161 TABLE 145 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 162 TABLE 146 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 162 TABLE 147 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 162 TABLE 148 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 162 TABLE 149 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 163 TABLE 150 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION) 163 TABLE 151 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION) 163 TABLE 152 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 164 TABLE 153 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 164 TABLE 154 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 164 TABLE 155 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 165 TABLE 156 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 166 TABLE 157 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 166 TABLE 158 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 166 TABLE 159 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 167 TABLE 160 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 168 TABLE 161 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 168 TABLE 162 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 168 TABLE 163 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 169 TABLE 164 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 169 TABLE 165 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 170 TABLE 166 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 170 TABLE 167 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 170 TABLE 168 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 171 TABLE 169 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 171 TABLE 170 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 172 TABLE 171 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 172 TABLE 172 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 172 TABLE 173 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 173 TABLE 174 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 173 TABLE 175 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION) 173 TABLE 176 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 174 TABLE 177 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 174 TABLE 178 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 174 TABLE 179 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 175 TABLE 180 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 175 TABLE 181 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 175 TABLE 182 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 176 TABLE 183 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 176 TABLE 184 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 176 TABLE 185 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 176 TABLE 186 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION) 177 TABLE 187 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION) 177 TABLE 188 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 177 TABLE 189 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 178 TABLE 190 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 178 TABLE 191 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 179 TABLE 192 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 180 TABLE 193 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 180 TABLE 194 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 180 TABLE 195 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 181 TABLE 196 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 181 TABLE 197 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 182 TABLE 198 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 182 TABLE 199 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 182 TABLE 200 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 183 TABLE 201 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 183 TABLE 202 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 184 TABLE 203 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 184 TABLE 204 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 185 TABLE 205 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 185 TABLE 206 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 185 TABLE 207 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 186 TABLE 208 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT) 186 TABLE 209 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT) 187 TABLE 210 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 187 TABLE 211 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 187 TABLE 212 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT) 187 TABLE 213 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT) 188 TABLE 214 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION) 188 TABLE 215 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION) 188 TABLE 216 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT) 189 TABLE 217 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT) 189 TABLE 218 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION) 189 TABLE 219 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION) 190 TABLE 220 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT) 190 TABLE 221 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT) 190 TABLE 222 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION) 191 TABLE 223 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION) 191 TABLE 224 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT) 191 TABLE 225 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT) 191 TABLE 226 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION) 192 TABLE 227 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION) 192 TABLE 228 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 192 TABLE 229 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 193 TABLE 230 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 193 TABLE 231 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 193 TABLE 232 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 194 TABLE 233 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 194 TABLE 234 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 195 TABLE 235 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 195 TABLE 236 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 196 TABLE 237 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 196 TABLE 238 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 196 TABLE 239 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 197 TABLE 240 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT) 197 TABLE 241 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT) 198 TABLE 242 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 198 TABLE 243 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 199 TABLE 244 MEDICAL FILTRATION MARKET: DEGREE OF COMPETITION 203 TABLE 245 MEDICAL FILTRATION MARKET: REGION FOOTPRINT 210 TABLE 246 MEDICAL FILTRATION MARKET: MATERIAL FOOTPRINT 211 TABLE 247 MEDICAL FILTRATION MARKET: PROCESS TECHNOLOGY FOOTPRINT 212 TABLE 248 MEDICAL FILTRATION MARKET: DESIGN/PROCESS FOOTPRINT 213 TABLE 249 MEDICAL FILTRATION MARKET: APPLICATION FOOTPRINT 214 TABLE 250 MEDICAL FILTRATION MARKET: END USER FOOTPRINT 215 TABLE 251 MEDICAL FILTRATION MARKET: KEY STARTUPS/SMES 218 TABLE 252 MEDICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 219 TABLE 253 MEDICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 220 TABLE 254 MEDICAL FILTRATION MARKET: DEALS, JANUARY 2019–JANUARY 2025 221 TABLE 255 MEDICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019–JANUARY 2025 222 TABLE 256 MEDICAL FILTRATION MARKET: OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2025 223 TABLE 257 MERCK KGAA: COMPANY OVERVIEW 224 TABLE 258 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 225 TABLE 259 MERCK KGAA: EXPANSIONS, JANUARY 2019–JANUARY 2025 228 TABLE 260 3M (SOLVENTUM): COMPANY OVERVIEW 231 TABLE 261 3M (SOLVENTUM): PRODUCTS/SOLUTIONS/SERVICES OFFERED 232 TABLE 262 3M (SOLVENTUM): OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2025 234 TABLE 263 DANAHER: COMPANY OVERVIEW 236 TABLE 264 DANAHER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 237 TABLE 265 DANAHER: DEALS, JANUARY 2019–JANUARY 2025 240 TABLE 266 DANAHER: OTHERS, JANUARY 2019–JANUARY 2025 241 TABLE 267 SARTORIUS AG: COMPANY OVERVIEW 243 TABLE 268 SARTORIUS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244 TABLE 269 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 247 TABLE 270 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 248 TABLE 271 ASAHI KASEI CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 249 TABLE 272 BAXTER: COMPANY OVERVIEW 251 TABLE 273 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252 TABLE 274 BAXTER: DEALS, JANUARY 2019–JANUARY 2025 254 TABLE 275 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 256 TABLE 276 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257 TABLE 277 VEOLIA: COMPANY OVERVIEW 261 TABLE 278 VEOLIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 262 TABLE 279 VEOLIA: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 266 TABLE 280 DONALDSON COMPANY, INC.: COMPANY OVERVIEW 268 TABLE 281 DONALDSON COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269 TABLE 282 DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025 270 TABLE 283 PARKER HANNIFIN CORP: COMPANY OVERVIEW 271 TABLE 284 PARKER HANNIFIN CORP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 272 TABLE 285 ENTEGRIS: COMPANY OVERVIEW 274 TABLE 286 ENTEGRIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275 TABLE 287 MANN+HUMMEL: COMPANY OVERVIEW 276 TABLE 288 MANN+HUMMEL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 277 TABLE 289 CORNING INCORPORATED: COMPANY OVERVIEW 279 TABLE 290 CRITICAL PROCESS FILTRATION, INC.: COMPANY OVERVIEW 280 TABLE 291 COBETTER: COMPANY OVERVIEW 281 TABLE 292 GRAVER TECHNOLOGIES: COMPANY OVERVIEW 282 TABLE 293 ERTELALSOP: COMPANY OVERVIEW 284 TABLE 294 KASAG SWISS AG: COMPANY OVERVIEW 285 TABLE 295 FILTROX AG: COMPANY OVERVIEW 286 TABLE 296 MEMBRANE SOLUTIONS: COMPANY OVERVIEW 287 TABLE 297 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW 288 TABLE 298 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 289 TABLE 299 MEDICAL FILTRATION SOLUTIONS LTD.: COMPANY OVERVIEW 290 TABLE 300 SEFAR AG: COMPANY OVERVIEW 291 TABLE 301 WALKER FILTRATION: COMPANY OVERVIEW 292 TABLE 302 SAINT-GOBAIN: COMPANY OVERVIEW 293 TABLE 303 STERIS: COMPANY OVERVIEW 294 TABLE 304 STERIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 295 TABLE 305 STERIS: DEALS, JANUARY 2019–JANUARY 2025 297 TABLE 306 FORTIVE: COMPANY OVERVIEW 299 TABLE 307 FORTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 300 TABLE 308 FORTIVE: DEALS, JANUARY 2019–JANUARY 2025 301 TABLE 309 OLYMPUS CORPORATION: COMPANY OVERVIEW 303 TABLE 310 OLYMPUS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 304 TABLE 311 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 305 TABLE 312 ECOLAB: COMPANY OVERVIEW 306 TABLE 313 ECOLAB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 307 TABLE 314 ECOLAB: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 308 TABLE 315 GETINGE: COMPANY OVERVIEW 310 TABLE 316 GETINGE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 311 TABLE 317 GETINGE: EXPANSIONS, JANUARY 2019–JANUARY 2025 312 TABLE 318 STEELCOBELIMED (METALL ZUG GROUP): COMPANY OVERVIEW 314 TABLE 319 STEELCOBELIMED (METALL ZUG GROUP): PRODUCTS/SOLUTIONS/ SERVICES OFFERED 315 TABLE 320 STEELCOBELIMED (METALL ZUG GROUP): DEALS, JANUARY 2019–JANUARY 2025 316 TABLE 321 ENDO-TECHNIK W. GRIESAT (CREO): COMPANY OVERVIEW 317 TABLE 322 ENDO-TECHNIK W. GRIESAT (CREO): PRODUCTS/SOLUTIONS/SERVICES OFFERED 317 TABLE 323 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): COMPANY OVERVIEW 319 TABLE 324 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): PRODUCTS/SOLUTIONS/SERVICES OFFERED 319 TABLE 325 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): DEALS, JANUARY 2019–JANUARY 2025 320 TABLE 326 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW 321 TABLE 327 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 322 TABLE 328 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 323 TABLE 329 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2019–JANUARY 2025 324 TABLE 330 BAXTER: COMPANY OVERVIEW 326 TABLE 331 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 327 TABLE 332 BAXTER: DEALS, JANUARY 2019–JANUARY 2025 328 TABLE 333 DAVITA INC.: COMPANY OVERVIEW 330 TABLE 334 DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 331 TABLE 335 DAVITA INC.: DEALS, JANUARY 2019–JANUARY 2025 331 TABLE 336 DAVITA INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025 332 TABLE 337 NIKKISO CO., LTD.: COMPANY OVERVIEW 333 TABLE 338 NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 334 TABLE 339 NIKKISO CO., LTD.: DEALS, JANUARY 2019–JANUARY 2025 335 TABLE 340 B. BRAUN SE: COMPANY OVERVIEW 337 TABLE 341 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 338 TABLE 342 B. BRAUN SE: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 339 TABLE 343 B. BRAUN SE: EXPANSIONS, JANUARY 2019–JANUARY 2025 339 TABLE 344 NIPRO: COMPANY OVERVIEW 341 TABLE 345 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 342 TABLE 346 NIPRO: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025 343 TABLE 347 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW 344 TABLE 348 TORAY MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 345 TABLE 349 MEDIONICS: COMPANY OVERVIEW 346 TABLE 350 MEDIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 346 _ FIGURE 1 MEDICAL FILTRATION MARKET AND REGIONAL SCOPE 33 FIGURE 2 MEDICAL FILTRATION MARKET: RESEARCH DESIGN 36 FIGURE 3 MEDICAL FILTRATION MARKET: BOTTOM-UP APPROACH 40 FIGURE 4 MEDICAL FILTRATION MARKET: TOP-DOWN APPROACH 41 FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL FILTRATION MARKET (TOP-DOWN APPROACH) 41 FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS 42 FIGURE 7 MEDICAL FILTRATION MARKET: DATA TRIANGULATION 43 FIGURE 8 POLYSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 47 FIGURE 9 DIALYSIS APPLICATION TO LEAD MARKET DURING FORECAST PERIOD 47 FIGURE 10 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 48 FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 49 FIGURE 12 GROWING FOCUS ON INFECTION CONTROL IN HEALTHCARE SECTOR TO DRIVE MARKET 50 FIGURE 13 POLYSULFONE & POLYETHERSULFONE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 50 FIGURE 14 IV INFUSION & STERILE FILTRATION SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 51 FIGURE 15 HOSPITALS TO BE LARGEST END USER SEGMENT DURING FORECAST PERIOD 51 FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 52 FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL FILTRATION MARKET 53 FIGURE 18 MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 59 FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 61 FIGURE 20 KEY BUYING CRITERIA FOR TOP THREE END USERS 62 FIGURE 21 MEDICAL FILTRATION MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 22 MEDICAL FILTRATION MARKET: ECOSYSTEM 68 FIGURE 23 MEDICAL FILTRATION MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77 FIGURE 24 EXPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 78 FIGURE 25 IMPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND) 79 FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 (USD/UNIT) 82 FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023 (USD/UNIT) 83 FIGURE 28 AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023 (USD/UNIT) 83 FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2020–2024 (USD MILLION) 84 FIGURE 30 PATENTS APPLIED AND GRANTED, 2014–2024 85 FIGURE 31 LEGAL STATUS OF PATENTS, 2014–2024 86 FIGURE 32 TOP JURISDICTIONS 86   FIGURE 33 POLYETHERSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 88 FIGURE 34 MICROFILTRATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 94 FIGURE 35 FILTRATION MODULES (CONSUMABLES) SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 100 FIGURE 36 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 104 FIGURE 37 DIALYSIS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 109 FIGURE 38 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 116 FIGURE 39 ASIA PACIFIC: MEDICAL FILTRATION MARKET SNAPSHOT 119 FIGURE 40 EUROPE: MEDICAL FILTRATION MARKET SNAPSHOT 138 FIGURE 41 NORTH AMERICA: MEDICAL FILTRATION MARKET SNAPSHOT 157 FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL FILTRATION MARKET BETWEEN 2019 AND 2024 201 FIGURE 43 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MEDICAL FILTRATION MARKET, 2021–2023 202 FIGURE 44 MARKET SHARE OF KEY COMPANIES IN MEDICAL FILTRATION MARKET, 2023 203 FIGURE 45 VALUATION OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023 205 FIGURE 46 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023 206 FIGURE 47 MEDICAL FILTRATION MARKET: PRODUCT COMPARISON ANALYSIS 206 FIGURE 48 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023 208 FIGURE 49 MEDICAL FILTRATION MARKET: OVERALL COMPANY FOOTPRINT 209 FIGURE 50 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023 217 FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT 225 FIGURE 52 3M (SOLVENTUM): COMPANY SNAPSHOT 232 FIGURE 53 DANAHER: COMPANY SNAPSHOT 237 FIGURE 54 SARTORIUS AG: COMPANY SNAPSHOT 244 FIGURE 55 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT 249 FIGURE 56 BAXTER: COMPANY SNAPSHOT 252 FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 257 FIGURE 58 VEOLIA: COMPANY SNAPSHOT 262 FIGURE 59 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT 269 FIGURE 60 PARKER HANNIFIN CORP: COMPANY SNAPSHOT 272 FIGURE 61 ENTEGRIS: COMPANY SNAPSHOT 275 FIGURE 62 MANN+HUMMEL: COMPANY SNAPSHOT 277 FIGURE 63 STERIS: COMPANY SNAPSHOT 295 FIGURE 64 FORTIVE: COMPANY SNAPSHOT 300 FIGURE 65 OLYMPUS CORPORATION: COMPANY SNAPSHOT 304 FIGURE 66 ECOLAB: COMPANY SNAPSHOT 307 FIGURE 67 GETINGE: COMPANY SNAPSHOT 311 FIGURE 68 STEELCOBELIMED (METALL ZUG GROUP): COMPANY SNAPSHOT 315   FIGURE 69 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT 322 FIGURE 70 BAXTER: COMPANY SNAPSHOT 327 FIGURE 71 DAVITA INC.: COMPANY SNAPSHOT 330 FIGURE 72 NIKKISO CO., LTD.: COMPANY SNAPSHOT 334 FIGURE 73 B. BRAUN SE: COMPANY SNAPSHOT 338 FIGURE 74 NIPRO: COMPANY SNAPSHOT 342 FIGURE 75 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT 345